Warfarin: Impact on hemostasis after radial catheterization

Area of Science:

• Cardiology
• Vascular Medicine
• Pharmacology

Background:

• Traditionally, warfarin was withheld before catheterization due to bleeding concerns.
• Radial artery access is increasingly used, prompting reevaluation of anticoagulation management.
• This study investigates hemostasis in patients on warfarin undergoing radial catheterization.

Purpose of the Study:

• To determine if patients taking warfarin have comparable hemostasis times to non-warfarin patients during radial catheterization.
• To assess the safety and efficacy of radial catheterization in patients on warfarin.
• To evaluate the impact of warfarin and antiplatelet agents on hemostasis duration.

Main Methods:

• Analysis of a convenience sample of 208 patients undergoing radial catheterization.
• Comparison of hemostasis times (defined as compression band times) between warfarin and non-warfarin groups.
• Statistical analysis using ANOVA and logistic regression, adjusting for aspirin and clopidogrel use.

Main Results:

• No significant difference in mean hemostasis times was observed between warfarin and non-warfarin patients (118 vs. 116 min, P=0.25).
• Aspirin use also did not significantly affect hemostasis times (117 vs. 114 min, P=0.70).
• A trend suggested clopidogrel might prolong hemostasis (123 vs. 114 min, P=0.09), though not statistically significant.

Conclusions:

• Adequacy of hemostasis and duration of compression were similar for patients on warfarin versus those not on warfarin.
• These findings suggest that warfarin may not need to be routinely held prior to radial catheterization when controlling for antiplatelet therapy.
• The study supports reconsidering current protocols regarding warfarin management in the context of radial artery procedures.